Taking aspirin could reduce the risk of hospitalized coronavirus patients falling severely ill or dying, a new study suggests.
Researchers found that a daily low-dose pill could lower the likelihood of being admitted to the ICU or being placed on a ventilator by more than 40 percent.
Additionally, it cut the risk of dying from the infection by nearly half.
The team, from the University of Maryland School of Medicine (UMSOM), says the findings provide ‘cautious optimism’ of the efficacy of this easy and accessible medication to help prevent severe complications.
‘This is a critical finding that needs to be confirmed through a randomized clinical trial,’ said study leader Dr Jonathan Chow, assistant professor of anesthesiology at UMSOM.
‘If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients.’
For the study, the journal Anesthesia and Analgesia, the team looked at the medical records of 412 COVID-19 patients treated at University of Maryland Medical Center in Baltimore and three other hospitals along the East Coast.
About one-quarter were taking a daily low-dose aspirin before or right after they were admitted to manage cardiovascular disease.
Researchers controlled for several factors such as age, sex, race, body mass index and underlying conditions such as hypertension and diabetes.
Those who used aspirin daily lowered the risk of ICU admission by 43 percent and lowered the risk of being put on a mechanical ventilator by 44 percent.
Click here to read more.
SOURCE: Daily Mail, Mary Kekatos